Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain: Harnessing innate immunity to enhance gene therapy

Ítems similars

• Long-term control of neuropathic pain in a non-viral gene therapy paradigm
  per: Sloane, EM, et al.
  Publicat: (2009)
• Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain
  per: MILLIGAN, ERIN D., et al.
  Publicat: (2006)
• Enduring Reversal of Neuropathic Pain by a Single Intrathecal Injection of Adenosine 2A Receptor Agonists: A Novel Therapy for Neuropathic Pain
  per: Loram, Lisa C., et al.
  Publicat: (2009)
• Intrathecal Interleukin-10 Gene Therapy Attenuates Paclitaxel-Induced Mechanical Allodynia and Proinflammatory Cytokine Expression in Dorsal Root Ganglia in Rats
  per: Ledeboer, Annemarie, et al.
  Publicat: (2006)
• Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy
  per: Sloane, Evan, et al.
  Publicat: (2008)